Global Enteral Nutrition Market value was US$ 8,182.73 million in 2022 and is estimated to surpass the market valuation of US$ 16,289.29 million by 2031, growing at a CAGR of 7.95% during the forecast period from 2023 to 2031.
The enteral nutrition market is exhibiting a sizable increase trend when taking into account the existing market dynamics. The most vulnerable to sickness and death are infants who are undernourished and lacking in essential vitamins and minerals. Therefore, this is the chosen method for feeding infants. The global market is also growing owing to an older population, a growing number of malnutrition victims receiving treatment, and falling product prices.
Get a Free Sample Report Here- https://www.astuteanalytica.com/request-sample/enteral-nutrition-market
Increased usage of enteral nutrition in patients admitted to hospitals or long-term care facilities due to an increase in the prevalence of chronic diseases like cancer is likely to propel market expansion in the coming years. For instance, on June 8, 2023, 1,603,844 new cancer cases were reported in the United States, while 602,347 persons died from cancer, according to data from the Centers for Disease Control and Prevention (CDC).
The use of enteral nutrition and the demand for sip feeds are likely to rise as the frequency of preterm births or premature births rises, helping to meet the nutritional needs of babies. For instance, a World Health Organization (WHO) article from May 10, 2023, estimated that worldwide, 13.4 million babies were born preterm in 2020 (before 37 weeks of gestation).
Another noticeable trend is the growing preference for in-home care, which is being fueled by both the need for more cozy and familiar surroundings for recuperation and the rising cost of healthcare. Numerous studies support the use of enteral feeds for patients with nutritional issues that grew worse during the epidemic, fueling industry expansion. For instance, several patients brought to the ICU for COVID-19 treatment suffered from acute malnourishment, according to a study published in the Journal of the Academy of Nutrition and Dietetics. As a result, the market is likely to see an increase in the use of enteral nutrition formulations.
Hospital Sales Generated More than 50% of Market Revenue Share
Hospital sales account for the highest revenue share of 63%. This predominance is due to the large proportion of hospitalized patients who need dietary support. The number of patients needing hospitalization and, consequently, nutritional care is likely to climb as the worldwide burden of chronic diseases continues to rise.
Additionally, the continuous initiatives to enhance hospital facilities and offerings, particularly in developing nations, would probably support rising hospital demand for enteral nutrition products. For instance, the Indian government exceeded its goal of creating 50,000 Health & Wellness Centers (HWCs) to over 1,60,000 operational HWCs by the end of last year, due to Ayushman Bharat.
As a result, the hospital sales segment of the enteral nutrition market will maintain its growth trajectory over the following years, with a projected CAGR of 7.96%. The expansion of this market highlights hospitals giving patients enteral nutritional support and enhancing their health outcomes.
North America Generated Robust Sales of the Global Market
In terms of revenue, North America led the global enteral nutrition market. This growth is due to the high prevalence of chronic diseases, significant healthcare costs, extensive insurance coverage, and a considerable number of hospitalizations.
According to the Rural Health Information Hub 2022, there will be about 90 million people in the US who are 65 or older by the year 2050, up from the current figure of more than 46 million. The incidence of the senior population is likely to boost this segment’s growth because enteral nutrition is used more frequently in this age range.
One of the biggest healthcare expenditures worldwide is found in North America, particularly in the United States. The amount spent on healthcare in the United States reached over US$ 4.1 trillion in 2021 or around 18% of the GDP. A strong healthcare system and the ability to pay for nutritional support systems like enteral nutrition for patients in need are indicated by such high expenditures.
Each year, hospital admission rates are high in both the United States and Canada. According to the Canadian Institute for Health Information, there will be about 1 million hospital admissions in Canada by 2020. nearly the same time period, nearly 36.5 million hospital admissions occurred in the United States for enteral feeding, according to the American Hospital Association. The fact that a large portion of these patients need food support while they are undergoing medical care increases the demand for enteral nutrition.
For the full report, please follow this link- https://www.astuteanalytica.com/industry-report/enteral-nutrition-market
List of Prominent Players Profiled
- Global Health Products, Inc.
- Mead Johnson Nutrition Company
- Meiji Holdings Co., Ltd.
- Nestlà Health Science
- Danone SA
- B. Braun Melsungen AG
- Victus, In.
- Abbott Laboratories
- Hormel Foods Corporation
- Fresenius Kabi AG
- Abbott Laboratories
- Other Prominent Players
Segmentation Outline
The global enteral nutrition market segmentation focuses on Type, Application, and Region.
By Type
- Standard Protein Diet
- High Protein Supplement
- Protein for Diabetes Care Patient
- Others
By Application
- Hospital Sales
- Retail
- Online
By Region
- North America
- The U.S.
- Canada
- Mexico
- Europe
- Western Europe
- The UK
- Germany
- France
- Italy
- Spain
- Rest of Western Europe
- Eastern Europe
- Poland
- Russia
- Rest of Eastern Europe
- Western Europe
- Asia Pacific
- China
- India
- Japan
- Australia & New Zealand
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- South Africa
- UAE
- Rest of MEA
- South America
- Argentina
- Brazil
- Rest of South America
Request a Free Sample Report Here- https://www.astuteanalytica.com/request-sample/enteral-nutrition-market
About Astute Analytica
Astute Analytica is a global analytics and advisory company that has built a solid reputation in a short period, thanks to the tangible outcomes we have delivered to our clients. We pride ourselves in generating unparalleled, in-depth and uncannily accurate estimates and projections for our very demanding clients spread across different verticals. We have a long list of satisfied and repeat clients from a wide spectrum including technology, healthcare, chemicals, semiconductors, FMCG, and many more. These happy customers come to us from all across the Globe. They are able to make well-calibrated decisions and leverage highly lucrative opportunities while surmounting the fierce challenges all because we analyze for them the complex business environment, segment-wise existing and emerging possibilities, technology formations, growth estimates, and even the strategic choices available. In short, a complete package. All this is possible because we have a highly qualified, competent, and experienced team of professionals comprising of business analysts, economists, consultants, and technology experts. In our list of priorities, you-our patron come at the top. You can be sure of best cost-effective, value-added package from us, should you decide to engage with us.
𝐆𝐞𝐭 𝐢𝐧 𝐭𝐨𝐮𝐜𝐡 𝐰𝐢𝐭𝐡 𝐮𝐬
𝐏𝐡𝐨𝐧𝐞 𝐧𝐮𝐦𝐛𝐞𝐫: +𝟏𝟖𝟖𝟖𝟒𝟐𝟗𝟔𝟕𝟓𝟕
𝐄𝐦𝐚𝐢𝐥: sales@astuteanalytica.com
𝐕𝐢𝐬𝐢𝐭 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞: https://www.astuteanalytica.com/